Necroptosis inducer 2
Necroptosis inducer 2 is a necroptosis inducer and copper chelator. Necroptosis inducer 2 chelates intracellular free copper ions, disrupts redox homeostasis, elevates ROS levels, disrupts mitochondrial membrane potential, and induces cancer cell necroptosis. Necroptosis inducer 2 upregulates the necroptosis markers p-MLKL and p-RIP3 expression. Necroptosis inducer 2 exhibits anti-tumor activity in mice. Necroptosis inducer 2 can be used for the research of cancer, such as triple-negative breast cancer.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Formel: C72H56Cl2N2O2P2
- Molecular Weight:1114.08
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
RIPK3 |
In Vitro
Necroptosis inducer 2 (Compound 2d) (20 μM) binds selectively and strongly to Cu2+ and Cu+ in a cell-free system, with Ka values of 1.42 × 104/M and 7.33 × 103/M, respectively[1].
Necroptosis inducer 2 (48 h) potently inhibits the proliferation of MDA-MB-231, 4T1, HeLa, HT29, A2780, and U-2 OS cancer cells with IC50 values ranging from 4.1-10.6 μM, shows moderate activity against A549 cells (IC50 = 29.4 μM), and exhibits reduced toxicity toward non-cancerous MCF-10A cells (IC50 = 10.6 μM)[1].
Necroptosis inducer 2 (10 μM; 44 h treatment) has its cytotoxicity rescued in MDA-MB-231 cells by exogenous Cu2+, confirming copper chelation is essential for its antiproliferative activity[1].
Necroptosis inducer 2 (10-20 μM; 24 h) reduces intracellular chelatable copper levels in MDA-MB-231 cells in a concentration-dependent manner, as detected by CS1 confocal microscopy[1].
Necroptosis inducer 2 (20 μM; 24 h) rescues MDA-MB-231 cells from CuCl2-induced cytotoxicity, demonstrating potent copper-chelating activity in a cellular context[1].
Necroptosis inducer 2 (5-20 μM; 24 h) elevates intracellular ROS levels and disrupts mitochondrial membrane potential in MDA-MB-231 cells in vitro in a concentration-dependent manner, and this effect is reversed by exogenous Cu2+[1].
Necroptosis inducer 2 (10 μM; 44 h) induces cell death in MDA-MB-231 cells primarily via the necroptosis pathway, as only Necrostatin-1 (HY-15760) rescues cell viability[1].
Necroptosis inducer 2 (5-20 μM; 24 h) upregulates the necroptosis markers p-MLKL and p-RIP3 in MDA-MB-231 cells in vitro in a concentration-dependent manner[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MDA-MB-231 cells
-
Concentration:5 μM, 10 μM, 20 μM
-
Incubation Time:24 h
-
Result:Caused a concentration-dependent upregulation of phosphorylated mixed lineage kinase domain-like (p-MLKL) and phosphorylated receptor-interacting protein kinase 3 (p-RIP3), key necroptosis markers.
Showed that markers for apoptosis, autophagy, and ferroptosis remained unchanged.
-
Cell Line:MDA-MB-231 cells
-
Concentration:10 μM, 20 μM
-
Incubation Time:24 h
-
Result:Caused a marked concentration-dependent increase in p-MLKL accumulation, providing direct visual evidence of necroptosis activation.
In Vivo
Necroptosis inducer 2 (5-20 mg/kg; intratumoral; 2 doses (day 1 and day 8 postmodeling)) exerts dose-dependent in vivo murine breast tumor growth inhibition, reaching 89.8% at 20 mg/kg with complete regression in some animals and no detectable hematological or systemic toxicity[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Breast cancer BALB/c mice (female, 4−6 weeks old, subcutaneous injection of 1 × 106 4T1 murine breast cancer cells)[1]
-
Dosage:5 mg/kg
-
Administration:intratumoral; 2 doses (day 1 and day 6 postmodeling)
-
Result:Achieved a tumor inhibition rate of 36.3%.
Showed no significant body weight loss compared to the control group.
Revealed no obvious histopathological damage in major organs via H&E staining.
Induced extensive necrosis and structural disruption in tumor tissue via H&E staining.
Downregulated PCNA expression in tumor tissue via immunohistochemical analysis.
Caused a significant increase in p-MLKL staining in tumor tissue via immunohistochemical analysis.
-
Animal Model:Breast cancer BALB/c mice (female, 4−6 weeks old, subcutaneous injection of 1 × 106 4T1 murine breast cancer cells)[1]
-
Dosage:5 mg/kg; 10 mg/kg; 20 mg/kg
-
Administration:intratumoral; 2 doses (day 1 and day 8 postmodeling)
-
Result:Inhibited tumor growth in a dose-dependent manner, with tumor inhibition rates of 35.3%, 58.8%, and 89.8% at 5, 10, and 20 mg/kg, respectively.
Induced complete tumor regression in 2 out of 5 mice in the 20 mg/kg group.
Showed no significant body weight changes across all treated groups.
Revealed no hematological toxicity compared to the control group via red blood cell and platelet parameter analysis.
Chemical Information
-
Molecular Weight 1114.08
-
Formel C72H56Cl2N2O2P2
-
SMILES
OC1=C(C=C(C=C1)C[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)/C=N/C5=C(C6=C(C=C5)C=CC=C6)C7=C8C(C=CC=C8)=CC=C7/N=C/C9=C(C=CC(C[P+](C%10=CC=CC=C%10)(C%11=CC=CC=C%11)C%12=CC=CC=C%12)=C9)O.[Cl-].[Cl-]
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Mitochondrial membrane-potential fluorescent assay
Mitochondrial membrane potential fluorescent assays estimate ΔΨm in living cells using lipophilic cationic dyes such as TMRM, TMRE, rhodamine 123, and JC-1, which accumulate in mitochondria according to membrane polarization; loss of signal after FCCP or CCCP treatment is interpreted as mitochondrial depolarization. TMRM/TMRE and rhodamine 123 are commonly used for semi-quantitative live-cell microscopy or flow cytometry, while JC-1 can report a shift from red aggregate fluorescence to green monomer fluorescence during depolarization; interpretation requires controls because dye concentration, quenching mode, cell type, dye efflux, and mitochondrial mass can affect fluorescence independently of ΔΨm.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Fluorescent plasma-membrane potential dye assay
Fluorescent plasma-membrane potential dye assays measure changes in cell membrane potential using voltage-sensitive dyes whose fluorescence changes when cells depolarize or hyperpolarize. Anionic bis-oxonol dyes such as DiBAC4(3) enter depolarized cells more readily and show increased fluorescence after intracellular binding, while hyperpolarization reduces dye accumulation and fluorescence. FMP/FLIPR membrane-potential dyes are used for faster, homogeneous microplate assays of ion-channel or receptor-mediated membrane-potential changes.
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Keywords
- Necroptosis inducer 2
- Necroptosis inducer2
- Necroptosis inducer-2
- Necroptosis
- Reactive Oxygen Species (ROS)
- Mitochondrial Metabolism
- Mixed Lineage Kinase
- RIP kinase
- necroptosis
- mitochondrial damage
- ovarian cancer
- osteosarcoma
- copper ions
- reactive oxygen species
- lung cancer
- triple-negative breast cancer
- colon cancer
- MDA-MB-231
- Inhibitor
- inhibitor
- inhibit